O

OKUR

OKUR

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
6%Bearish
Buy/Sell Ratio43% buys
BearishBullish
OKUR Live QuoteReal-time
$2.76
+$0.46(+20.00%)1M
Day Range$2.70 – $2.96
Open$2.83
Previous Close$2.82
Volume136.1K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$113.68M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.26
Price to Book0.7
Dividend Yield0.65%
Beta (Volatility)0.73
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $2.76 (22%)
Low: $2.01High: $5.38
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$15.25-89.8% upside

Insider Buys

1

$2.59M

Insider Sales

16

$3.43M

Total Volume

$6.02M

17 transactions

Net Activity

$841K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
42CONFIDENCE

Sentiment Rating

Neutral / Balanced

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Moderate distribution: sales represent 57% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
C
1

Cormorant Asset Management, LP

Former 10% Owner

0 buys2 sells

$3.41M total

A
2

Acorn Bioventures, L.P.

10%

1 buys0 sells

$2.59M total

L
3

Leverone Jason A.

CFO

0 buys7 sells

$15K total

S
4

Saccomano Nicholas A

Pres, CEO

0 buys7 sells

$4K total

Trading History
OKUR insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 21, 2026

2 months ago

Saccomano Nicholas A

Pres, CEO

CEO
Sell87$2.97$259

Sep 21, 2026

2 months ago

Leverone Jason A.

CFO

CFO
Sell302$2.97$898

Jun 22, 2026

5 months ago

Saccomano Nicholas A

Pres, CEO

CEO
Sell86$4.40$378

Jun 22, 2026

5 months ago

Leverone Jason A.

CFO

CFO
Sell303$4.40$1K

Mar 23, 2026

8 months ago

Saccomano Nicholas A

Pres, CEO

CEO
Sell86$4.16$357

Mar 23, 2026

8 months ago

Leverone Jason A.

CFO

CFO
Sell301$4.16$1K

Dec 22, 2025

11 months ago

Saccomano Nicholas A

Pres, CEO

CEO
Sell87$2.97$258

Dec 22, 2025

11 months ago

Leverone Jason A.

CFO

CFO
Sell302$2.97$896

Sep 22, 2025

14 months ago

Saccomano Nicholas A

Pres, CEO

CEO
Sell88$2.62$231

Sep 22, 2025

14 months ago

Leverone Jason A.

CFO

CFO
Sell303$2.62$795

Jun 23, 2025

17 months ago

Saccomano Nicholas A

Pres, CEO

CEO
Sell88$2.38$210

Jun 23, 2025

17 months ago

Leverone Jason A.

CFO

CFO
Sell303$2.38$722

May 15, 2025

18 months ago

Cormorant Asset Management, LP

Former 10% Owner

10% Owner
Sell1.81M$1.85$3.36M

May 15, 2025

18 months ago

Acorn Bioventures, L.P.

10%

10% Owner
Buy1.40M$1.85$2.59M

May 12, 2025

18 months ago

Cormorant Asset Management, LP

10%

10% Owner
Sell24.3K$1.99$48K

Apr 4, 2025

19 months ago

Saccomano Nicholas A

Pres, CEO

CEO
Sell874$2.94$3K

Apr 4, 2025

19 months ago

Leverone Jason A.

CFO

CFO
Sell3.1K$2.94$9K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
OKUR Buy Conviction43%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.53B

OKUR has an insider buy conviction of 43%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for OKUR

Over the last 90 days, corporate insiders at OKUR (OKUR) engaged in a total of 17 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 16 were sales. The total volume of insider trading reached $6.02M.

The net insider activity for OKUR shows a net selling bias of $841K. This activity represents a 43% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Cormorant Asset Management, LP (Former 10% Owner), who traded 1.81M shares valued at $3.36M on May 15, 2025.

Live Market News & Developments
Aggregated real-time headlines for OKUR (OKUR)
6 updates

OKUR - OnKure Therapeutics Inc Stock Price and Quote

Finviz177d ago

OnKure Therapeutics Rings the Nasdaq Stock Market Closing Bell

Nasdaq109d ago

symbol__ Stock Quote Price and Forecast

CNN772d ago

Insiders' US$16.6m Investments In Red Following OnKure Therapeutics' US$19m Dip In Market Value

Simply Wall St69d ago

OnKure Therapeutics, Inc. (OKUR) stock price, news, quote and history

Yahoo Finance UK774d ago

OKUR Stock Price and Chart — NASDAQ:OKUR

TradingView773d ago

FAQs About OKUR Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for OKUR.

Based on SEC Form 4 disclosures, the Insider Confidence Score for OKUR is currently 42/100, which reflects a neutral / balanced bias. This calculation accounts for a total of 1 purchases and 16 sales by company executives over the last 90 days.

The CEO Conviction Index for OKUR is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.